|
|
|||
| |||||||||||||||||||||||||||||||
These are exciting times for investigators of neuromuscular diseases. With the explosion of information about the human genome, we are advancing on the mysteries of many diseases, such as Duchenne's muscular dystrophy, that were formerly thought to be unsolvable. Exciting advances in research on amyotrophic lateral sclerosis include the identification of the locus for the gene in familial cases, the identification of unique electrophysiologic features that herald a more benign prognosis for some patients, and the recognition of immunologic abnormalities that may identify a treatable form of the disease. Of particular interest is a new approach to therapy that uses
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |